Atopic Eczema Treatment Market Size, Share Report, Analysis, Trends, Growth, 2030

Atopic Eczema Treatment Industry Prospective:

The global atopic eczema treatment market size was evaluated at $10 billion in 2022 and is slated to hit $13 billion by the end of 2030 with a CAGR of nearly 7.14% between 2023 and 2030.

Request Free Sample

Atopic Eczema Treatment Market: Overview

Atopic eczema is a skin disorder resulting in dry, cracked, and itchy skin. Moreover, atopic eczema can be treated and the treatment is referred to as a complete approach for treating atopic eczema. The treatment for atopic eczema includes skin rehydration by using ointments and topical steroids to reduce inflammation and skin itching. The disease is modifiable and includes inhalant and food allergens and non-modifiable as can be due to hereditary features.

Key Insights

• As per the analysis shared by our research analyst, the global atopic eczema treatment market is projected to expand annually at the annual growth rate of around 7.14% over the forecast timespan (2023-2030)
• In terms of revenue, the global atopic eczema treatment market size was evaluated at nearly $10 billion in 2022 and is expected to reach $13 billion by 2030.
• The global atopic eczema treatment market is anticipated to grow rapidly over the forecast timeline owing to the rise in the incidences of skin diseases in children and adult population and the need for effectively curing them.
• In terms of drug class, the biologics segment is slated to register the highest CAGR over the analysis period.
• Based on route of administration, the injectable segment is expected to dominate the segmental growth over the assessment timeline.
• Region-wise, the Asia-Pacific atopic eczema treatment industry is projected to register the fastest CAGR during the assessment timeline.

Request Free Sample

Atopic Eczema Treatment Market: Growth Factors

Increment in cases of skin disorders to boost the global market trends over forecasting years

Rise in the incidences of skin diseases in children & adult population and the need for effectively curing them has prompted the demand for atopic eczema treatment. A surge in awareness about the treatment of the disease among people will further steer the global atopic eczema treatment market growth. Favorable government schemes and promotions regarding the treatment of skin diseases will proliferate the size of the market across the globe. Rise in the use of medicines such as antibiotics and corticosteroids in treating eczema will drive the global market trends.

Supportive compensation policies will drive the expansion of the market across the globe in the coming years. New product launches are anticipated to provide a boost to the global market expansion in the coming years. For instance, in the first half of 2022, Sanofi S.A., a key healthcare firm based in France, launched dupilumab for children aged between 6 months to 5 years and received the green signal from the U.S. FDA for treating atopic eczema. Such moves are likely to boost the size of the global market in the years ahead.

Atopic Eczema Treatment Market: Restraints

Increase in skin order treatment costs can hinder the global industry growth over forecasting period

Rise in the treatment costs can retard the growth of the atopic eczema treatment industry across the globe. Long-term treatment and hospital visits can prove to be cumbersome and burdensome for the patients, thereby decreasing the global industry demand.

Atopic Eczema Treatment Market: Opportunities

Rise in the geriatric populace susceptible to skin ailments can create new opportunities of growth for the global market

Increase in the aging population prone to suffer from skin disorders will open new growth opportunities for the global atopic eczema treatment market.

Atopic Eczema Treatment Market: Challenges

Less adherence to various medical therapies can put up a big challenge for the global industry

Fewer adherence to medical treatment and topical medications can prove to be a huge challenge for the global atopic eczema treatment industry.

Atopic Eczema Treatment Market: Segmentation

The global atopic eczema treatment market is sectored into drug class, route of administration, and region.                

In drug class terms, the global atopic eczema treatment market is segregated into biologics and PDE4 inhibitors segments. Furthermore, the biologics segment, which gathered nearly half of the global market revenue share in 2022, is projected to register the highest CAGR in the upcoming years. The growth of the segment in the estimated timespan can be owing to the ability of biologics in targeting skin inflammations.  

Based on the route of administration, the global atopic eczema treatment industry is sectored into injectable, topical, and oral segments. Moreover, the injectable segment, which garnered a huge chunk of the global industry revenue share in 2022, is projected to lead the global industry over the analysis timeframe. The segmental expansion over the assessment period can be owing to a rise in the use of injectables such as dupilumab along with the massive application of ruxolitinib and tofacitinib in treating various kinds of skin diseases including eczema.

Atopic Eczema Treatment Market: Report Scope

Atopic Eczema Treatment Market: Regional Insights

North America is anticipated to retain dominating position in the global Atopic Eczema Treatment market over the anticipated timeline

North America, which contributed about half of the global atopic eczema treatment market revenue in 2022, will be a leading region over the projected timeframe. Furthermore, the regional market growth can be subject to a rise in the presence of giant firms such as AbbVie as well as Viatris in the countries such as the U.S. Furthermore, additionally, the availability of strong healthcare infrastructure facilities and increase in the healthcare spending favorably impact the regional market expansion.

Asia-Pacific atopic eczema treatment industry is set to register the fastest CAGR in the forthcoming years owing to favorable healthcare policies of governments in countries such as India and China. Moreover, a rise in the availability of effective treatment at reasonable costs in these countries will drive regional industry trends.

 Atopic Eczema Treatment Market: Competitive Space

The global atopic eczema treatment market profiles key players such as:

• Pfizer Inc.
• AbbVie Inc.
• GALDERMA LABORATORIES
• L.P.
• Otsuka Pharmaceutical Co. Ltd.
• Regeneron Pharmaceuticals Inc.
• Incyte Corporation
• Sanofi
• Novartis AG
• Eli Lilly and Company (Dermira)
• LEO Pharma Inc.

The global atopic eczema treatment market is segmented as follows:

By Drug Class

• Biologics
• PDE4 Inhibitors

By Route of Administration

• Topical
• Injectable
• Oral

By Region

• North America
  • The U.S.
  • Canada
• Europe
  • France 
  • The UK
  • Spain
  • Germany
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • South Africa
  • Rest of Middle East & Africa